MONTE MOORE: Open Payments
NPI 1558829382 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 29 payments from 9 companies in 2025. Trend: 2023 $956 · 2024 $971 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $223 |
| ABBVIE INC. | 9 | $156 |
| Supernus Pharmaceuticals, Inc. | 1 | $109 |
| Corium, LLC | 5 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Auvelity, VRAYLAR, Qelbree, Azstarys, Jornay PM, SPRAVATO, JOURNAVX, COBENFY.
Industry payments across LA — which companies pay providers there.
